Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Report Date: August 6, 2026
Reporting Period: Fiscal Second Quarter ended June 30, 2026
This filing serves as a notification that the Company announced its financial results for the second quarter of 2026 via a press release. The detailed financial data is contained within the press release attached as Exhibit 99.1, which is incorporated by reference but explicitly stated as "furnished" rather than "filed" for liability purposes under Section 18 of the Exchange Act.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. Consequently, the following metrics are not available in this document:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not disclose specific material changes, year-over-year comparisons, or variance analysis. Investors must refer to the attached press release (Exhibit 99.1) for details on operational or financial changes versus the prior comparable period.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the announcement of Q2 2026 results but does not include management commentary, forward-looking guidance, or specific risk factors within the text of the 8-K itself.
Unusual Items: No unusual items are described in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 6, 2026) for actual revenue, net income, and cash flow figures.
- Verify the specific definitions of "furnished" versus "filed" information regarding liability under Section 18 of the Exchange Act as noted in Item 2.02.
- Check for any updated forward-looking statements or guidance included in the press release that may not be reflected in this summary.
- Confirm the trading symbol ORGO on the Nasdaq Capital Market for current stock performance relative to the announcement.